Cancer remains a significant global health challenge, with chronic inflammation often playing a role in tumor development and progression. , As a result, the search for novel anti-inflammatory agents to complement conventional cancer therapies is vital. Triiptolide, a synthetic derivative of the natural product triptolide, has emerged as a promisin

Barzolvolimab: A Novel Possibility for Autoimmune Diseases? Barzolvolimab, a newly identified therapeutic compound, is creating considerable excitement within the scientific field. This innovative molecule functions as a powerful blocker of immune 17F, a key mediator in the development of various inflammatory diseases, including IBD. Initial clini